Peri-implant Bone Healing and Osseointegration
Conditions
Brief summary
Kaempferol gel was tested as a local adjunct during implant placement in 30 patients. Compared to controls, the Kaempferol group showed significantly higher ALP activity at 2 and 4 weeks and greater bone density gain after 6 months (40.73% vs. 33.21%). These findings suggest Kaempferol enhances early bone remodeling, improves peri-implant bone quality, and may allow earlier implant loading.
Detailed description
This randomized controlled clinical trial investigated the effect of Kaempferol gel, a natural antioxidant and bone-healing compound, on dental implant healing in the maxillary posterior region. Thirty patients were divided into two groups: one received Kaempferol gel during implant placement, while the other did not. The study measured alkaline phosphatase (ALP) activity in peri-implant crevicular fluid at 1, 2, and 4 weeks, and bone density using CBCT at baseline and 6 months. Results showed that Kaempferol significantly boosted ALP activity at 2 and 4 weeks, suggesting faster bone remodeling. At 6 months, bone density improved in both groups, but the Kaempferol group showed a greater increase (40.73% vs. 33.21%). In conclusion, Kaempferol gel enhanced early bone healing and improved bone density around implants, indicating its potential as a cost-effective, biocompatible adjunct to accelerate osseointegration and possibly allow earlier implant loading, particularly in patients with poor bone quality.
Interventions
Local topical application of Kaempferol gel into the implant site during one-stage delayed implant placement to enhance peri-implant bone healing and osseointegration.
Sponsors
Study design
Eligibility
Inclusion criteria
* At least one missing maxillary posterior tooth with a healed ridge
Exclusion criteria
* Previous bone grafting at the implant site.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| alkaline phosphatase level | at baseline, 1,2, 4 weeks | Change in alkaline phosphatase (ALP) activity measured in peri-implant crevicular fluid (PICF) using ELISA to evaluate early bone remodeling activity. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Bone density around implants | Baseline and 6 months postoperatively | Change in peri-implant bone density assessed by cone beam computed tomography (CBCT) at the implant site |
Countries
Egypt